Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

BioNTech initiates global trials of mRNA-based lung cancer vaccine
Clinical Trials Arena
Monday, August 26, 2024 - 10:16am
tags:
BioNTech, BNT116, non-small cell lung cancer, MRNA, clinical trials
J&J's bid to change pay model for Stelara, Xarelto slammed
Pharmaphorum
Monday, August 26, 2024 - 10:16am
tags:
JNJ, Stelara, 340B, Xarelto
Mixed reactions among HCPs as lecanemab and donanemab secure FDA approval for Alzheimer's treatment
Pharmaphorum
Monday, August 26, 2024 - 10:14am
tags:
Alzheimer's disease, physicians, Eli Lilly, Kisunla, donanemab, lecanemab
MBX files for IPO, seeking cash to take challenger to Ascendis' Yorvipath into phase 3
Fierce Biotech
Monday, August 26, 2024 - 10:09am
tags:
MBX Biosciences, IPOs, Ascendis Pharma, Yorvipath
Bayer layoffs hit Switzerland with 150 cuts at Basel consumer health hub
Fierce Pharma
Sunday, August 25, 2024 - 11:09pm
tags:
Bayer, consumer health, layoffs, Switzerland
Nestle to keep Health Science unit after CEO's exit, chairman tells paper
Reuters
Sunday, August 25, 2024 - 11:04pm
tags:
Nestle
Novartis receives binding offer from Siemens Healthineers for molecular imaging business
Reuters
Sunday, August 25, 2024 - 11:02pm
tags:
Novartis, M&A, Siemens Healthineers, molecular imaging
Microbot advances Liberty robotic system to next phase of remote telesurgery evaluation
Clinical Trials Arena
Sunday, August 25, 2024 - 11:00pm
tags:
Medtech, Microbot, Liberty system, robotic surgery
Biopharma VC hit highest quarterly level since 2022, but challenges in exit landscape remain
Fierce Biotech
Friday, August 23, 2024 - 11:25am
tags:
venture capital, funding
Gene Editing Startup Tome Struggles to Stay Afloat Just Months After Launching
BioSpace
Friday, August 23, 2024 - 11:11am
tags:
Tome Bioscience, gene editing
Illumina Ventures seeks $300m for third fund
Global Venturing
Friday, August 23, 2024 - 11:05am
tags:
Illumina Ventures, CVC, venture capital, funding
Ozempic on Wall Street's list for 2027 Medicare drug negotiations
Reuters
Friday, August 23, 2024 - 10:59am
tags:
Ozempic, Novo Nordisk, Pfizer, GSK, Medicare, drug pricing
Bicara and Zenas file for IPOs to push late-phase prospects toward finish line
Fierce Biotech
Friday, August 23, 2024 - 10:57am
tags:
Bicara Therapeutics, Zenas BioPharma, IPOs
FDA weighs limiting PD-1 drugs in stomach cancer, calls on experts to discuss Merck, BMS and BeiGene meds
Fierce Pharma
Friday, August 23, 2024 - 10:55am
tags:
FDA, stomach cancer, Bristol Myers Squibb, Opdivo, Yervoy, Merck, Keytruda, BeiGene, Tevimbra
FDA grants IND clearance for Galapagos’ non-Hodgkin lymphoma therapy trial
Clinical Trials Arena
Friday, August 23, 2024 - 10:49am
tags:
Galapagos, non-Hodgkin lymphoma, clinical trials, GLPG5101
Walgreens Is Reportedly Considering a Drastic Move to Improve Its Cash Flow
Motley Fool
Friday, August 23, 2024 - 10:46am
tags:
Walgreens, pharmacies, VillageMD
AstraZeneca dismisses rumors of facility relocation to US
Pharmaphorum
Friday, August 23, 2024 - 10:44am
tags:
AstraZeneca, UK, vaccines, drug manufacturing
Jazz’s cannabidiol therapy flunks in Japanese Phase III trial
Clinical Trials Arena
Friday, August 23, 2024 - 10:42am
tags:
Jazz Pharma, Cannabidiol, Japan, Epidiolex
Updated COVID shots from Pfizer, Moderna cleared by FDA
BioPharma Dive
Thursday, August 22, 2024 - 10:03pm
tags:
COVID-19, vaccines, Pfizer, Moderna Therapeutics, FDA
Bristol-Myers Squibb-backed Zenas BioPharma files for US IPO
Reuters
Thursday, August 22, 2024 - 10:01pm
tags:
Zenas BioPharma, IPOs, Bristol Myers Squibb

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.